You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti inflammatory treatment

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Microbiome, Recurrent Pregnancy Loss Trial in Ashdod (coulture)

Not yet recruiting
  • Microbiome
  • Recurrent Pregnancy Loss
  • coulture
  • Ashdod, Israel
    Assuta Ashdod University Hospital
Nov 3, 2022

Advanced Solid Cancers, Advanced Solid Cancers Refractory to PD-1 Trial in United States (AGEN1884)

Completed
  • Advanced Solid Cancers
  • Advanced Solid Cancers Refractory to PD-1
  • Duarte, California
  • +10 more
Apr 28, 2022

Disease Flares and Patient Adaptation in Relation to Events in

Active, not recruiting
  • Inflammatory Bowel Diseases
  • Coronavirus Infection
    • Hull, United Kingdom
      Gastroenterology, Hull Royal Infirmary, Hull University Teaachin
    Oct 4, 2021

    Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

    Recruiting
    • Melanoma (Excluding Uveal Melanoma)
    • +15 more
    • XmAb®23104
    • Yervoy® (ipilimumab)
    • San Diego, California
    • +15 more
    Sep 20, 2021

    RWD Study in HER2+ mBC Patients in Third-Line Therapy

    Completed
    • Breast Cancer Stage IV
    • No intervention
    • Moncton, New Brunswick, Canada
    • +7 more
    Oct 6, 2021

    COVID-19 - Cytokine Storm

    Recruiting
    • COVID-19
    • No intervention
    • Jerusalem, Israel
      Hadassah Medical Center
    Dec 20, 2020

    Heart Diseases, Coronary Disease, Coronary Artery Disease Trial in Lancaster (Clopidogrel, Aspirin)

    Enrolling by invitation
    • Heart Diseases
    • +9 more
    • Lancaster, Pennsylvania
      Amish Research Clinic
    Jan 24, 2022

    Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

    Completed
    • Refractory Cancer
    • Seoul, Korea, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022

    Glioblastoma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)

    Recruiting
    • Glioblastoma
    • Tislelizumab plus Bevacizumab
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Aug 14, 2022

    Autoimmune Diseases, IBD, Crohn Disease (CD) Trial in Aabenraa, Herlev, Odense (Primary exposure variable, Other (exploratory)

    Completed
    • Autoimmune Diseases
    • +9 more
    • Primary exposure variable
    • Other (exploratory) exposure variables
    • Aabenraa, Denmark
    • +2 more
    Jun 30, 2021

    Nutritional Status, Eating Habits and Improvement of Symptoms

    Recruiting
    • Endometriosis
    • Nutritional intervention
    • Pavia, Italy
      University of Pavia
    May 18, 2022

    Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis, Nr-axSpA Trial in Worldwide (Certolizumab Pegol, Placebo)

    Completed
    Has Results
    • Axial Spondyloarthritis
    • +2 more
    • Certolizumab Pegol
    • Placebo
    • Birmingham, Alabama
    • +104 more
    Aug 16, 2022

    Acute Pain, Cancer Pain Trial in Santiago (Acetaminophen, Placebo)

    Completed
    • Acute Pain
    • Cancer Pain
    • Santiago, Chile
      Universidad Catolica de Chile
    Aug 12, 2021

    Melanoma Trial in Moscow (Anti-PD-1 mAb)

    Recruiting
    • Melanoma
    • Anti-PD-1 monoclonal antibody
    • Moscow, Russian Federation
      N.N. Blokhin Russian Cancer Research Center, Kashirskoye shosse
    Jun 13, 2021

    Interaction, Adverse Herb-Drug, Diabetes, Type 2 Trial in Spokane (Midazolam Hcl 1Mg/Ml Inj, Goldenseal (Hydrastis canadensis))

    Active, not recruiting
    • Interaction, Adverse Herb-Drug
    • Diabetes Mellitus, Type 2
    • Midazolam Hcl 1Mg/Ml Inj
    • Goldenseal (Hydrastis canadensis)
    • Spokane, Washington
      Washington State University College of Pharmacy and Pharmaceutic
    Nov 18, 2022

    Postoperative Nausea and Vomiting, Surgery, Anesthesia Trial in Hefei (Sulfentanyl, Nalbuphine, flubiprofen axetil)

    Unknown status
    • Postoperative Nausea and Vomiting
    • +4 more
    • Hefei, Anhui, China
      the First Affiliated Hospital of Anhui Medical University
    Feb 19, 2018

    Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Histamine Dihydrochloride (HDC)
    • Interleukin-2 (IL-2)
    • (no location specified)
    Mar 31, 2023

    Rheumatoid Arthritis Trial in Ankara (exercise training group, control training group)

    Not yet recruiting
    • Rheumatoid Arthritis
    • exercise training group
    • control training group
    • Ankara, Turkey
      Gazi University
    Feb 15, 2022

    Metastatic Renal Cell Carcinoma Trial in Cleveland (Nivolumab, Ipilimumab)

    Active, not recruiting
    • Metastatic Renal Cell Carcinoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 25, 2023

    Malignant Melanoma Trial in Worldwide (Atezolizumab, Cobimetinib)

    Completed
    Has Results
    • Malignant Melanoma
    • Scottsdale, Arizona
    • +42 more
    Nov 17, 2021

    Cold Exposure, Hyperventilation, Inflammation Trial in Nijmegen (Cold Exposure, Strength Ventilation)

    Completed
    • Cold Exposure
    • +3 more
    • Cold Exposure
    • Strength Ventilation
    • Nijmegen, Netherlands
      Radboud University Medical Centre, Intensive Care
    Mar 29, 2019

    Systemic Lupus Erythematosus Trial in United States (Hydroxychloroquine, Placebo Oral Capsule)

    Recruiting
    • Systemic Lupus Erythematosus
    • Los Angeles, California
    • +6 more
    Oct 29, 2021

    HIV Trial (Anti-HIV Immune Serum Globulin (Human), Zidovudine)

    Terminated
    • HIV Infections
    • (no location specified)
    Oct 28, 2021

    HIV/AIDS Trial in Atlanta (Genvoya)

    Completed
    Has Results
    • HIV/AIDS
    • Atlanta, Georgia
      Hope Clinic
    Jul 20, 2021

    Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic acid, Low-dose aspirin)

    Recruiting
    • Hydroxychloroquine
    • Assiut, Egypt
      Abdel-rahman Mahmoud Mohammed
    Jul 21, 2021